GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lotus Pharmaceutical Co Ltd (OTCPK:LTPCF) » Definitions » Other Income (Expense)

Lotus Pharmaceutical Co (Lotus Pharmaceutical Co) Other Income (Expense) : $29.97 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Lotus Pharmaceutical Co Other Income (Expense)?

Lotus Pharmaceutical Co's other income expense for the Lotus Pharmaceutical Co's pretax income for the three months ended in Mar. 2024 was $5.71 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was $29.97 Mil.


Lotus Pharmaceutical Co Other Income (Expense) Historical Data

The historical data trend for Lotus Pharmaceutical Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lotus Pharmaceutical Co Other Income (Expense) Chart

Lotus Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.92 0.79 -6.06 6.90 23.36

Lotus Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.09 1.34 6.70 16.22 5.71

Lotus Pharmaceutical Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $29.97 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lotus Pharmaceutical Co  (OTCPK:LTPCF) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Lotus Pharmaceutical Co (Lotus Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
Song Ren Road, 17th Floor, No. 277, Xin Yi District, Taipei, TWN, 110
Lotus Pharmaceutical Co Ltd is engaged in the healthcare sector. It is engaged in generic drug business segment, which engages mainly in the research and development, manufacturing and sales of generic pharmaceutical products. It has its geographic presence in United States, South Korea and Others.

Lotus Pharmaceutical Co (Lotus Pharmaceutical Co) Headlines

From GuruFocus